|
1.
|
Landsteiner K: Zur Kenntnis der
antifermentativen, lytischen und agglutinierenden Wirkungen des
Blutserums und der Lymphe. Zentralbl Bakteriol. 27:357–362.
1900.(In German).
|
|
2.
|
Bang YJ, Van Cutsem E, Feyereislova A, et
al ToGA Trial Investigators: Trastuzumab in combination with
chemotherapy versus chemotherapy alone for treatment of
HER2-positive advanced gastric or gastro-oesophageal junction
cancer (ToGA): a phase 3, open-label, randomized controlled trial.
Lancet. 376:687–697. 2010. View Article : Google Scholar
|
|
3.
|
Bang Y, Chung H, Sawaki A, Xu J, Shen L,
Lipatov O, Park SR, Gangadharan VP, Advani SH and Kang YK:
HER-2-positivity rates in advanced gastric cancer (GC): Results
from a large international phase III trial. J Clin Oncol.
26(Suppl)4526:2008
|
|
4.
|
Bang Y, Chung H, Xu J, Lordick F, Sawaki
A, Al-Sakaff N, Lipatov O, See C, Rueschoff J and Van Cutsem E:
Pathological features of advanced gastric cancer (GC): Relationship
to human epidermal growth factor receptor 2 (HER2) positivity in
the global screening programme of the ToGA trial. J Clin Oncol.
27(Suppl)4556:2009
|
|
5.
|
Schoppmann SF, Jesch B, Friedrich J, Wrba
F, Schultheis A, Pluschnig U, Maresch J, Zacherl J, Hejna M and
Birner P: Expression of Her-2 in carcinomas of the esophagus. Am J
Surg Pathol. 34:1868–1873. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Aird I, Bentall HH and Roberts JA: A
relationship between cancer of stomach and the ABO blood groups. Br
Med J. 1:799–801. 1953. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Edgren G, Hjalgrim H, Rostgaard K, Norda
R, Wikman A, Melbye M and Nyren O: Risk of gastric cancer and
peptic ulcers in relation to ABO blood type: a cohort study. Am J
Epidemiol. 172:1280–1285. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Hofmann M, Stoss O, Shi D, Buttner R, van
de Vijver M, Kim W, Ochiai A, Ruschoff J and Henkel T: Assessment
of a HER2 scoring system for gastric cancer: results from a
validation study. Histopathology. 52:797–805. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Fridey J: Standards for Blood Banks and
Transfusion Services. 22nd edition. American Association of Blood
Banks; Bethesda, MD: 2002
|
|
10.
|
Siewert JR and Stein HJ: Classification of
adenocarcinoma of the oesophagogastric junction. Br J Surg.
85:1457–1459. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Lauren P: The two histological main types
of gastric carcinoma: Diffuse and so-called intestinal-type
carcinoma. An attempt at a histo-clinical classification. Acta
Pathol Microbiol Scand. 64:31–49. 1965.
|
|
12.
|
Lee JS, Ro JY, Sahin AA, Hong WK, Brown
BW, Mountain CF and Hittelman WN: Expression of blood-group antigen
A - a favorable prognostic factor in non-small-cell lung cancer. N
Engl J Med. 324:1084–1090. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Gates MA, Wolpin BM, Cramer DW, Hankinson
SE and Tworoger SS: ABO blood group and incidence of epithelial
ovarian cancer. Int J Cancer. 128:482–486. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Dabelsteen E and Gao S: ABO blood-group
antigens in oral cancer. J Dent Res. 84:21–28. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Wolpin BM, Chan AT, Hartge P, Chanock SJ,
Kraft P, Hunter DJ, Giovannucci EL and Fuchs CS: ABO blood group
and the risk of pancreatic cancer. J Natl Cancer Inst. 101:424–431.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Lennon AM, Klein AP and Goggins M: ABO
blood group and other genetic variants associated with pancreatic
cancer. Genome Med. 2:392010. View
Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Ürün Y, Utkan G, Yalcin Ş, et al: Lack of
any relationship between ABO and Rh blood groups and
clinicopathological features in patients with gastrointestinal
stromal tumors: Turkish Oncology Group. Asian Pac J Cancer Prev.
13:4129–4131. 2012.PubMed/NCBI
|
|
18.
|
Costantini M, Fassio T, Canobbio L,
Landucci M, Resasco M and Boccardo F: Role of blood groups as
prognostic factors in primary breast cancer. Oncology. 47:308–312.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Aird I, Bentall HH, Mehigan JA and Roberts
JA: The blood groups in relation to peptic ulceration and carcinoma
of colon, rectum, breast, and bronchus; an association between the
ABO groups and peptic ulceration. Br Med J. 2:315–321. 1954.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Goldenberg IS and Hayes MA: Breast
carcinoma and ABO blood groups. Cancer. 11:973–974. 1958.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Dede DS, Aksoy S, Dizdar O, Cerci P, Gullo
I, Ozisik Y and Altundag K: Blood ABO groups and risk of breast
cancer. Med Oncol. 27:14332010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Stamatakos M, Kontzoglou K, Safioleas P,
Safioleas C, Manti C and Safioleas M: Breast cancer incidence in
Greek women in relation to ABO blood groups and Rh factor. Int
Semin Surg Oncol. 6:142009. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Urun Y, Koru-Sengul T, Altundag K, Utkan
G, Onur H, Akbulut H, Demirkazik A and Icli F: ABO blood group and
the risk of breast cancer: Multicenter, case-control, observational
study. J Clin Oncol. 30(Suppl)1572:2012
|
|
24.
|
Ürün Y, Utkan G, Altundag K, et al: ABO
and Rh blood groups frequency in women with HER2 positive breast
cancer. J BUON. 17:457–460. 2012.PubMed/NCBI
|
|
25.
|
Klimant E, Glurich I, Mukesh B and Onitilo
AA: Blood type, hormone receptor status, HER2/neu status, and
survival in breast cancer: a retrospective study exploring
relationships in a pheno-typically well-defined cohort. Clin Med
Res. 9:111–118. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Austrian Red Cross: Blood Groups.
https://www.roteskreuz.at/home/. Accessed
July 19, 2012.
|
